Key result
Fetuses and neonates exhibit higher circulating thrombopoietin concentrations and increased sensitivity of megakaryocyte progenitor cells to thrombopoietin compared to children or adults.
Answers are grounded in this paper and cite their sources.
This review highlights the unique developmental biology of thrombopoietin in fetuses and neonates, emphasizing the need for further studies to optimize treatment for neonatal thrombocytopenia.
This review focuses on the biology of thrombopoietin (Tpo) during human development. It summarizes the current understanding on molecular biological aspects of Tpo, cellular effects of Tpo on fetal and neonatal megakaryopoiesis, regulation of Tpo production, and circulating Tpo concentrations in human fetuses and neonates. Some important aspects on the developmental biology of Tpo are highlighted. They include the finding of high Tpo gene expression in the bone marrow during the onset of medullary hematopoiesis, higher circulating Tpo concentrations in fetuses and neonates than in children or adults, and a higher sensitivity of neonatal megakaryocyte progenitor cells to Tpo. However, other aspects of the developmental biology of Tpo are incompletely understood. Conclusion: More carefully designed studies are needed to provide the necessary background for an optimal treatment of fetal and neonatal thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Christof Dame (2002) conducted a review in Fetal and neonatal thrombocytopenia. Thrombopoietin (Tpo) was evaluated. Fetuses and neonates exhibit higher circulating thrombopoietin concentrations and increased sensitivity of megakaryocyte progenitor cells to thrombopoietin compared to children or adults.
Synapse has enriched 10 related papers. Consider them for comparative context: